MenuClose
ESMO 2026On demandMadrid, October 23–27See the ESMO 2026 highlightsSubscribe to the newsletter

Recent coverage

ESMO 2026On demandMadrid, October 23–27See the ESMO 2026 highlights

More tumor sites

Across disciplines

NADIM: five-year outcomesPerioperative chemotherapy plus nivolumab in resectable stage IIIA NSCLC: 5-year progression-free survival of 65%.Latest highlight, from The Lancet Oncology

The 2026 program

The OncoAlert Colloquium emblemThe OncoAlert ColloquiumThe year in review in oncology, one tumor group a day. Free for oncology professionals.

Listen to Oncology Here & Now

The newest Horizons discussionAdjuvant treatment challenges in early HR+/HER2− breast cancer, with Dr. Sibylle Loibl and Dr. Rupert Bartsch.

Lung and thoracic cancers

On The Go

Short upright videos. Tap one to watch, then swipe for the next.

Podium2Screen

Podium2Screen videos on lung and thoracic cancers, newest first.

The series

Highlights

Paper picks on lung and thoracic cancers, newest first.

Videos

Round-ups and expert picks on lung and thoracic cancers, newest first.

Oncology Here & Now

The podcast: short conversations, one tumor type at a time.

All episodes

From the Colloquium

7 talks from the lung cancer and supportive care day of the sixth OncoAlert Colloquium, February 2026.

Thoracic oncology, then supportive care organized by our partners at MASCC.

Moderated by Dr. Gil Morgan and Dr. Oriol Mirallas.

The whole ColloquiumThe whole day on Vimeo

  1. Early NSCLCDr. Gilberto Lopes
  2. Advanced NSCLCDr. Biagio Ricciuti
  3. SCLC and mesotheliomaDr. Giannis Mountzios
  4. DiagnosticsDr. Umberto Malapelle
  5. Lung cancer radiotherapyDr. Gerry Hanna
  6. The patient advocate’s perspectiveJill Feldman
  7. How I treat when options are limitedDr. Uğur Özkerim

Faculty

The OncoAlert faculty for lung and thoracic cancers, in a new order on every visit.

All faculty

Past congresses

Each opens that congress’s highlights, showing only lung and thoracic cancers.

All congresses